Skip to main content
. Author manuscript; available in PMC: 2011 Jul 9.
Published in final edited form as: Genet Med. 2009 Oct;11(10):750–756. doi: 10.1097/GIM.0b013e3181b3a697

Table 3.

Rationales for testing

Observed interrater agreement (%) Kappa Number of cases for which both observers agreed that this rationale was present (%)
To explain a clinical event 88 0.74 153 (58)
To direct clinical management 89 0.61 31 (12)
Because of family history of VTE, FVL, or both 91 0.75 48 (18)
Because of patient request 94 0.67 19 (7)
Because of patient anxiety 96 0.55 8 (3)
Unclear/unknown 91 0.64 27 (10)